Delivery Order SPE2DB24D9211-SPE2DB25FBNQQ
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems on August 21, 2025, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the prime contractor on this firm fixed-price delivery order, which carries no set-aside designation. This award represents a discrete delivery order issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its primary location. The company has been registered in the System for Award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $3,124.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 28, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The award carries no set-aside designation, and performance will be executed in Park...
- The Defense Logistics Agency awarded a $14,008.45 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on August 19, 2025, with an ultimate completion date of September 10, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. No set-aside designation was applied to this award, allowing the company to compete directly in the open federal...
- SPE2DB24D9211Indefinite Delivery Contract
- SPE2DB24D9211-SPE2DB25FBNQQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The company leverages its position as a prime contractor under the DLA's SPE2DB Indefinite Delivery Contract program, a $499.999 billion vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with consistent contract awards for diverse medical products ranging from contraceptive devices to specialty medications and oncology treatments. The company's federal contracting history demonstrates its capacity to deliver prescription medications, biologics, and medical consumables to Department of Defense healthcare sites nationwide. This delivery order for Mirena systems—a contraceptive implant used in military and federal healthcare settings—reflects the ongoing demand for pharmaceutical inventory replenishment through the established IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/8/25 |